Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
NuGen Medical Devices Inc (TSE:NGMD)
TSXV:NGMD
RESEARCH TOOLSreports
NuGen Medical Devices Inc (NGMD) Stock Price & Analysis
11 Followers
NGMD Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.08 - C$0.25
Previous CloseC$0.14
Volume41.00K
Average Volume (3M)248.83K
Market Cap
C$27.80M
Enterprise ValueC$33.72M
Total Cash (Recent Filing)C$1.67M
Total Debt (Recent Filing)C$7.59M
Price to Earnings (P/E)―
Beta1.53
Next Earnings
Aug 26, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding216,425,682
10 Day Avg. Volume205,764
30 Day Avg. Volume248,830
Standard Deviation0.37
R-Squared0.09
Alpha0.00116
Financial Highlights & Ratios
Price to Book (P/B)-3.78
Price to Sales (P/S)-617.72
Price to Cash Flow (P/CF)-5.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
NuGen Medical Devices Inc News
PremiumCompany Announcements
NuGen Secures Major Repeat Order in Mexico
PremiumCompany Announcements
NuGen Targets $10M Raise for Expansion Efforts
PremiumCompany Announcements
NuGen Partners to Train Pharmacists in Canada
PremiumCompany Announcements
NuGen Readies for InsuJet™ Launch in BrazilPremiumCompany Announcements
NuGen Sees Growing Demand for InsuJet in YemenPremiumCompany Announcements
NuGen Secures Lucrative InsuJet Order for International Launch
PremiumCompany Announcements
NuGen Advances Commercial Strategy Post-Q1 Results
PremiumCompany Announcements
NuGen Restructures Debt, Focuses on GrowthOptions Prices
Currently, No data available
---
Ownership Overview
8.88% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
91.12% Public Companies and
Individual Investors
NGMD FAQ
What was NuGen Medical Devices Inc’s price range in the past 12 months?
NuGen Medical Devices Inc lowest stock price was C$0.08 and its highest was C$0.25 in the past 12 months.
What is NuGen Medical Devices Inc’s market cap?
Currently, no data Available
When is NuGen Medical Devices Inc’s upcoming earnings report date?
NuGen Medical Devices Inc’s upcoming earnings report date is Aug 26, 2024 which is in 35 days.
How were NuGen Medical Devices Inc’s earnings last quarter?
Currently, no data Available
Is NuGen Medical Devices Inc overvalued?
According to Wall Street analysts NuGen Medical Devices Inc’s price is currently Overvalued.
Does NuGen Medical Devices Inc pay dividends?
NuGen Medical Devices Inc does not currently pay dividends.
What is NuGen Medical Devices Inc’s EPS estimate?
NuGen Medical Devices Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NuGen Medical Devices Inc have?
NuGen Medical Devices Inc has 198,543,120 shares outstanding.
What happened to NuGen Medical Devices Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of NuGen Medical Devices Inc?
Currently, no hedge funds are holding shares in TSE:NGMD
---
NuGen Medical Devices Inc Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Sold Shares
Worth C$58.6K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-26.31%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-20.27%
Trailing 12-Months
Company Description
NuGen Medical Devices Inc
NuGen Medical Devices Inc is an emerging specialty medical device company focused on developing and commercializing novel drug delivery technologies. Its principal business is the research, development and commercialization of innovative needle-free injection devices and systems for the administration of subcutaneous medication. The company is developing products using needlefree drug delivery technology in several important fields including, but not limited to, anaphylaxis, diabetes, severe migraine, erectile dysfunction, chronic anaemia, neutropenia, autoimmune rheumatoid arthritis, growth and fertility hormone, psoriasis as well as DNA and conventional/pediatric vaccines.
---
Technical Analysis
---